HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial targets Tough-to-Treat rare cancers
Disease control TerminatedThis study is testing an experimental drug called XmAb20717 in adults with advanced rare cancers that have few treatment options. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. The trial is currently suspended and is not enrolling …
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Scientists supercharge Patient's own cells to hunt lymphoma
Disease control OngoingThis early-phase study tests a new cell therapy for patients whose Hodgkin's or Non-Hodgkin's lymphoma has returned. Doctors take a patient's own immune cells, genetically modify them in a lab to better recognize and attack cancer cells, and then infuse them back. The main goal i…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Can better doctor talk ease the cancer survivor journey?
Symptom relief OngoingThis study aims to improve the experience for lymphoma survivors by training their doctors in better communication skills. It involves 314 patients with Hodgkin's or Diffuse Large B-cell Lymphoma who have finished curative treatment and are in remission. The research will measure…
Matched conditions: HODGKIN'S LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Mar 17, 2026 13:08 UTC